SCHEMBL15525872

SCHEMBL15525872

O=C(O)N1CCCC1COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 4/20 0.49
DAGLA Q9Y4D2 5/20 0.43
ABHD6 Q9BV23 4/20 0.43
SLC6A11 P48066 1/20 0.42
LMNA P02545 2/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA5 P30532 1/20 0.42
CHRNA7 P36544 1/20 0.42
CHRNA4 P43681 1/20 0.42
FFAR1 O14842 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 1/20 0.39
MEN1 O00255 1/20 0.39
GMNN O75496 1/20 0.39
BLM P54132 1/20 0.39
PMP22 Q01453 1/20 0.39
KMT2A Q03164 1/20 0.39
KCNK3 O14649 1/20 0.39
ABHD11 Q8NFV4 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10118446 0.82 SLC6A11 (0.55) SLC6A1SLC6A11FFAR1CYP3A4MEN1
SCHEMBL764125 0.79 SLC6A11 (0.52) SLC6A1SLC6A11FFAR1CYP3A4MEN1
SCHEMBL4140738 0.78 ABHD6 (0.54) DAGLAABHD6CHRNB2CHRNA5CHRNA7
SCHEMBL15811746 0.78 ABHD6 (0.54) DAGLAABHD6CHRNB2CHRNA5CHRNA7
SCHEMBL26502803 0.77 SLC6A11 (0.52) SLC6A1DAGLAABHD6SLC6A11FFAR1
SCHEMBL27138500 0.77 RIPK1 (0.40) SLC6A1SLC6A11MEN1KMT2ARIPK1
SCHEMBL19617254 0.76 ABHD6 (0.56) DAGLAABHD6CHRNB2CHRNA5CHRNA7
SCHEMBL15811762 0.76 ABHD6 (0.56) DAGLAABHD6CHRNB2CHRNA5CHRNA7
SCHEMBL6360197 0.76 ABHD6 (0.56) DAGLAABHD6CHRNB2CHRNA5CHRNA7
SCHEMBL5413716 0.75 FFAR1 (0.55) DAGLAABHD6CHRNB2CHRNA5CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2838535-A1 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE Biocryst Pharmaceuticals, Inc. (US) 2015-02-25 EP disclosed
WO-2013158746-A1 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE BIOCRYST PHARMACEUTICALS, INC. (US) 2013-10-24 WO disclosed